If you have been doing everything right and conception still isn't happening, there is a question worth asking. And a clinically proven answer most doctors never mention.
When couples face fertility challenges, the investigation almost always starts with her. Ovulation tracking. Hormone panels. HSG tests. Months of appointments, stress, and expense — while the male side goes largely unexamined.
The research tells a different story. Male factor infertility contributes to roughly half of all cases where conception is not happening. And at the center of male fertility is one hormone that most men over 28 are already losing.
Testosterone is not just about energy or muscle. It is the primary signal that drives sperm production in the testes. When testosterone drops — which happens gradually, silently, and often without any obvious symptoms — sperm count drops with it. Motility suffers. Morphology suffers. Conception becomes genuinely difficult even when everything else looks normal.
The conversation most couples never have is not about whether he is "sick." It is about whether his hormones are where they need to be to give you both the best chance.
See the ProtocolAccording to the American Society for Reproductive Medicine, male factor infertility is involved in approximately 50% of all cases where couples struggle to conceive.
Men lose roughly 1 to 2% of their testosterone per year beginning in their late 20s. By 35, many men have clinically suboptimal levels without any obvious warning signs.
Studies estimate that as few as 12% of men with low testosterone are ever formally evaluated or treated, leaving the majority unaware their hormones are affecting their fertility.
In clinical trials, men on testosterone replacement therapy showed significant reduction in sperm counts — in some cases to zero. The therapy that fixes one problem creates another.
A prescription protocol that works with the body's own hormonal system — not against it.
Low testosterone creates a hormonal signal breakdown between the brain and the testes. The body stops telling itself to produce enough testosterone or sperm.
Enclomiphene blocks the estrogen receptors that suppress the pituitary — restoring the natural signal that tells the testes to produce testosterone and sperm.
Clinical trials show testosterone levels normalizing within 3 to 4 weeks. Sperm counts improve significantly within 3 to 6 months in men with secondary hypogonadism.
Unlike testosterone replacement, this protocol preserves the body's own production. If stopped, the body continues naturally. No dependency. No shutdown.
This is for couples who are serious about finding real answers, not another supplement that makes vague promises.
Six months of trying without success is clinically significant. Before pursuing expensive interventions, understanding whether male hormone levels are a factor costs far less and takes far less time.
This is not about blame. It is about information. A simple physician assessment and optional lab work can determine whether hormone levels are playing a role — and whether this protocol is appropriate.
IVF is expensive, physically demanding, and emotionally exhausting. Before reaching that point, understanding and addressing male hormonal factors is a clinically sound, far less invasive first step.
A physician assessment can be completed online. No referral required. No waiting room. Results within 24 hours. If the protocol is appropriate, it ships within 48 hours of assessment completion.
Share this with him. A three-minute assessment. A physician review within 24 hours. A protocol that works with his body — naturally, from within.
See the Protocol